Herbas VPB

Print
EN | LT
LT - SIGNIFICANCE OF INTRATUMORAL HER2 HETEROGENEITY IN BREAST CANCER AND USES THEREFOR
EN - SIGNIFICANCE OF INTRATUMORAL HER2 HETEROGENEITY IN BREAST CANCER AND USES THEREFOR

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12Q 1/6886
G01N 33/574
European patent
(11) Number of the document 3152577
(13) Kind of document T
(96) European patent application number 15726957.2
Date of filing the European patent application 2015-06-03
(97) Date of publication of the European application 2017-04-12
(45) Date of publication and mention of the grant of the patent 2018-07-18
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2015/062331
Date 2015-06-03
PCT application publication
(87) Number WO 2015/185595
Date 2015-12-10
Priority applications
(30) Number Date Country code
201462009057 P 2014-06-06 US
Inventors
(72)
NITTA, Hiro, US
PADILLA, Mary T., US
RANGER-MOORE, James, US
DENNIS, Eslie, US
KUROZUMI, Sasagu, JP
KUROSUMI, Masafumi, JP
Grantee
(73) Ventana Medical Systems, Inc., 1910 Innovation Park Drive, Tucson, AZ 85755, US
Title
(54) SIGNIFICANCE OF INTRATUMORAL HER2 HETEROGENEITY IN BREAST CANCER AND USES THEREFOR
  SIGNIFICANCE OF INTRATUMORAL HER2 HETEROGENEITY IN BREAST CANCER AND USES THEREFOR
Last update date 2021-04-30